Drugs / UIC202502
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07162441 | Aug → Sep 2025 overdue | hyperlipidemia | Korea United Pharm. Inc. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UIC202502 | “UIC202502 1 Tab/day for 7 days” NCT07162441 ↗ |